SG10202005439XA - Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method - Google Patents

Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method

Info

Publication number
SG10202005439XA
SG10202005439XA SG10202005439XA SG10202005439XA SG10202005439XA SG 10202005439X A SG10202005439X A SG 10202005439XA SG 10202005439X A SG10202005439X A SG 10202005439XA SG 10202005439X A SG10202005439X A SG 10202005439XA SG 10202005439X A SG10202005439X A SG 10202005439XA
Authority
SG
Singapore
Prior art keywords
monoclonal antibody
stem cell
mesenchymal stem
human mesenchymal
evaluating quality
Prior art date
Application number
SG10202005439XA
Other languages
English (en)
Inventor
Yumi Iyoku
Hideyuki Okano
Yo Mabuchi
Original Assignee
Purec Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purec Co Ltd filed Critical Purec Co Ltd
Publication of SG10202005439XA publication Critical patent/SG10202005439XA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0663Bone marrow mesenchymal stem cells (BM-MSC)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/02Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/10Protein-tyrosine kinases (2.7.10)
    • C12Y207/10001Receptor protein-tyrosine kinase (2.7.10.1)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/912Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
SG10202005439XA 2014-08-01 2015-07-31 Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method SG10202005439XA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014157367 2014-08-01

Publications (1)

Publication Number Publication Date
SG10202005439XA true SG10202005439XA (en) 2020-07-29

Family

ID=55217690

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10202005439XA SG10202005439XA (en) 2014-08-01 2015-07-31 Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method
SG11201610795VA SG11201610795VA (en) 2014-08-01 2015-07-31 Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201610795VA SG11201610795VA (en) 2014-08-01 2015-07-31 Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method

Country Status (8)

Country Link
US (2) US20170204374A1 (ja)
EP (1) EP3176253B1 (ja)
JP (3) JP6850944B2 (ja)
AU (1) AU2015297347B2 (ja)
CA (1) CA2954245C (ja)
ES (1) ES2927112T3 (ja)
SG (2) SG10202005439XA (ja)
WO (1) WO2016017795A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11293065B2 (en) 2016-03-14 2022-04-05 Aelan Cell Technologies, Inc. Compositions and methods for the quality control of stem cell preparations
WO2020205732A1 (en) * 2019-03-29 2020-10-08 The Johns Hopkins University Grid of responses indicating drug sensitivity
CN112094804B (zh) * 2019-06-18 2024-05-14 中国医学科学院基础医学研究所 一种异质性干细胞群、其制备方法及用途
WO2021033247A1 (ja) 2019-08-19 2021-02-25 セルアクシア株式会社 細胞含有医薬組成物
WO2021144995A1 (ja) * 2020-01-16 2021-07-22 PuREC株式会社 高純度間葉系幹細胞
WO2022163872A1 (ja) * 2021-01-29 2022-08-04 国立大学法人北海道大学 椎間板再生用組成物
AU2022222868A1 (en) 2021-02-19 2023-09-07 Purec Co., Ltd. Pharmaceutical composition for treating bone diseases
JP7368679B2 (ja) * 2021-09-01 2023-10-25 イミュニティリサーチ株式会社 細胞集団同定システム、方法、およびプログラム
CN116486909A (zh) * 2022-01-14 2023-07-25 天士力干细胞产业平台有限公司 一种干细胞质量评价系统

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050148506A1 (en) 2003-04-16 2005-07-07 Wyeth Novel method of modulating bone-related activity
PT1978993T (pt) * 2005-10-31 2017-03-17 Oncomed Pharm Inc Composições e métodos para diagnóstico e tratamento do cancro com base em recetores fzd humanos
PE20071309A1 (es) * 2006-02-17 2008-02-13 Wyeth Corp Anticuerpos para la modulacion de formacion de huesos
US8491885B2 (en) 2007-07-16 2013-07-23 Catholic University Industry Academic Cooperation Foundation Method for promoting the self-renewal of adult stem cells using mesenchymal stromal cells
JP2009060840A (ja) 2007-09-06 2009-03-26 Keio Gijuku ヒト間葉系幹細胞濃縮方法
US20130209415A1 (en) 2010-06-03 2013-08-15 The Board Of Trustees Of The Leland Stanford Junior University Purified compositions of cardiovascular progenitor cells
EP2624846A2 (en) 2010-10-08 2013-08-14 Osiris Therapeutics, Inc. Nanoparticle-loaded cells
JP2013066414A (ja) * 2011-09-22 2013-04-18 National Institute Of Advanced Industrial Science & Technology 胃前駆細胞の表面マーカー
JP6463029B2 (ja) * 2013-08-02 2019-01-30 有未 伊谷 ヒト間葉系幹細胞を特異的に認識するモノクローナル抗体並びにこれを用いたヒト間葉系幹細胞の分離及び/または品質評価を行う方法
KR101987395B1 (ko) 2014-05-01 2019-06-10 아이하트 재팬 가부시키가이샤 Cd82 양성 심근 전구세포

Also Published As

Publication number Publication date
JP2021100414A (ja) 2021-07-08
EP3176253A4 (en) 2018-03-21
JPWO2016017795A1 (ja) 2017-06-22
JP2020072662A (ja) 2020-05-14
US20210230553A1 (en) 2021-07-29
US20170204374A1 (en) 2017-07-20
AU2015297347A1 (en) 2017-01-19
ES2927112T3 (es) 2022-11-02
CA2954245C (en) 2023-07-25
EP3176253A1 (en) 2017-06-07
CA2954245A1 (en) 2016-02-04
AU2015297347B2 (en) 2021-05-27
SG11201610795VA (en) 2017-02-27
JP6850944B2 (ja) 2021-04-14
JP6932390B2 (ja) 2021-09-08
WO2016017795A1 (ja) 2016-02-04
EP3176253B1 (en) 2022-08-24
US11441123B2 (en) 2022-09-13

Similar Documents

Publication Publication Date Title
SG10202005439XA (en) Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method
HK1252857A1 (zh) 抗cd3抗體及其使用方法
IL261941A (en) Chimeric antigen and t cell receptors and methods of use
HK1258931A1 (zh) 培養細胞的方法及用於該方法的試劑盒和設備
HK1244492A1 (zh) 抗pd-1抗體及其使用方法
HK1258933A1 (zh) 培養細胞的方法及用於該方法的試劑盒和設備
SG10201912494TA (en) Anti-cd3-binding domains and antibodies comprising them, and methods for their generation and use
SG11201705252UA (en) Anti-pd-1 monoclonal antibodies and obtaining method thereof
HK1251969A1 (zh) 抗her2抗體和使用方法
DK3105252T3 (da) Bispecifikke antistoffer til anvendelse ved stamcelletransplantation
IL251128A0 (en) Bispecific antibodies and methods of use in ophthalmology
ZA201700488B (en) Method for positioning, in cytoplasm, antibody having complete immunoglobulin form by penetrating antibody through cell membrane, and use for same
HK1244017A1 (zh) 在間充質幹細胞中批量生產蛋白質的方法
SG10202106515SA (en) Methods and kits for generating mimetic innate immune cells from pluripotent stem cells
HK1247100A1 (zh) Dna抗體構建體及其使用方法
HK1256804A1 (zh) 抗cd154抗體及其使用方法
SG10201912734PA (en) Chimeric antigen receptor, and t cells in which chimeric antigen receptor is expressed
IL252008A0 (en) Methods for producing bispecific domains, variants of antibodies and their use
GB201617572D0 (en) Use, method, kit, composition and antibodies
HK1220727A1 (zh) 使用綿羊 細胞產生抗體的方法及其用途
SG11201610878QA (en) Mutant hemagglutinin complex protein, and method for culturing pluripotent stem cells using same
IL273987A (en) Methods for diagnosing mesenchymal stem cells
GB201518076D0 (en) Methods and kits for determining deacylase activity
SG11201608489VA (en) Enrichment and characterization of human corneal endothelial cells (hcenc) with novel monoclonal antibody
HK1254737A1 (zh) 幹細胞培養方法